BIOCON PHARMA INC — Calcium Importer Profile
Pharmaceutical Importer · #4 buyer for Calcium · $46.1M import value · 1,229 shipments · UNITED STATES · DGFT Verified
BIOCON PHARMA INC is the #4 importer of Calcium from India with $46.1M in import value and 1,229 verified shipments. BIOCON PHARMA INC holds a 5.4% market share in Calcium imports based in UNITED STATES. The company sources from 3 verified suppliers across 632 formulations shipped to 2 countries. Overall, BIOCON PHARMA INC imports 7 pharmaceutical products worth $110.0M across 4 therapeutic categories.
BIOCON PHARMA INC — Calcium Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Calcium to BIOCON PHARMA INC?
Verified from 1,229 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BIOCON PHARMA LIMITED | $33.9M | 866 | 73.5% |
| GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $12.1M | 357 | 26.2% |
| BIOCON BIOLOGICS LIMITED | $143.7K | 6 | 0.3% |
BIOCON PHARMA INC sources Calcium from 3 verified Indian suppliers based on 1,229 customs records. The primary supplier is BIOCON PHARMA LIMITED accounting for 73.5% of imports.
How Does BIOCON PHARMA INC Compare to Nearest Calcium Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | BIOCON PHARMA INC ★ | UNITED STATES | $48.6M | 973 | $50.0K |
| 7 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $23.5M | 939 | $25.0K |
| 2 | APOTEX CORP | UNITED STATES | $14.4M | 289 | $50.0K |
BIOCON PHARMA INC ranks #4 among 2,554 Calcium importers from India. Average shipment value of $50.0K compared to the market average of $51.1K. The closest competitors by value are YUSEN LOGISTICS BENELUX BELGIUM and APOTEX CORP.
Where Does BIOCON PHARMA INC Import Calcium To?
Destination countries from 1,229 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $46.0M | 1,226 | 99.8% |
| UNITED STATES OF AMERICA | $109.8K | 3 | 0.2% |
BIOCON PHARMA INC imports Calcium to 2 countries. The primary destination is UNITED STATES receiving 99.8% of shipments worth $46.0M.
What Calcium Formulations Does BIOCON PHARMA INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| ATORVASTATIN CALCIUM TABLETS USP 40MG, B | $930.4K | 31 |
| ATORVASTATIN CALCIUM TABLETS USP 40MG (1 | $924.6K | 19 |
| ATORVASTATIN CALCIUM TABLETS USP 10MG (8 | $750.0K | 15 |
| Atorvastatin Calcium Tablets USP 80 mg.B | $714.1K | 26 |
| ROSUVASTATIN CALCIUM TABLETS 40MG (30S B | $704.2K | 22 |
| Rosuvastatin Calcium Tablets 10mg (90s b | $650.0K | 13 |
| ATORVASTATIN CALCIUM TABLETS USP 80MG (1 | $568.8K | 14 |
| Rosuvastatin Calcium Tablets 20mg (90s b | $500.0K | 10 |
| Rosuvastatin Calcium Tablets 20mg (500s | $450.0K | 9 |
| ATORVASTATIN CALCIUM TABLETS USP 80MG, B | $439.9K | 15 |
BIOCON PHARMA INC imports 632 distinct Calcium formulations from India. The top formulation is ATORVASTATIN CALCIUM TABLETS USP 40MG, B with 31 shipments worth $930.4K.
Regulatory Requirements: Importing Calcium into United States
What BIOCON PHARMA INC and other importers must comply with to import Calcium from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Calcium
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Calcium from India and How Much Does BIOCON PHARMA INC Import?
India exported $130.5M worth of Calcium through 15,000 shipments from 996 suppliers to 184 countries, serving 2,554 buyers globally. BIOCON PHARMA INC imports $46.1M of this total, accounting for 5.4% of India's Calcium exports with 1,229 shipments from UNITED STATES. This is verified from 1,229 customs shipment records covering 632 distinct formulations.
What Is the Average Order Value for BIOCON PHARMA INC's Calcium Imports?
BIOCON PHARMA INC's average Calcium order value is $37.5K per consignment, based on 1,229 shipments totaling $46.1M. BIOCON PHARMA INC is based in UNITED STATES and ranks #4 among all Calcium importers from India by value. The company sources from 3 verified suppliers in India.
Who Supplies Calcium to BIOCON PHARMA INC?
BIOCON PHARMA INC sources Calcium from 3 verified Indian suppliers: BIOCON PHARMA LIMITED ($33.9M, 73.5%), GRAVITI PHARMACEUTICALS PRIVATE LIMITED ($12.1M, 26.2%), BIOCON BIOLOGICS LIMITED ($143.7K, 0.3%). This is based on 1,229 customs records.
How Does BIOCON PHARMA INC Compare to Other Calcium Importers?
BIOCON PHARMA INC ranks #4 among 2,554 Calcium importers from India with a 5.4% market share. The top 3 importers are BIOCON PHARMA INC ($48.6M), YUSEN LOGISTICS BENELUX BELGIUM ($23.5M), APOTEX CORP ($14.4M). BIOCON PHARMA INC processed 1,229 shipments from UNITED STATES.
What Other Vitamins & Supplements Products Does BIOCON PHARMA INC Import?
BIOCON PHARMA INC also imports these vitamins & supplements products. Each links to the detailed product page.
About BIOCON PHARMA INC
BIOCON PHARMA INC imports 7 products worth $110.0M. Beyond Calcium, top products include Rosuvastatin, Atorvastatin, Esomeprazole, Magnesium, Tacrolimus. View the complete BIOCON PHARMA INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Calcium — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Calcium shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BIOCON PHARMA INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BIOCON PHARMA INC's capped import value divided by total capped export value for Calcium across all Indian exporters.
- 5.Verified Records: This page is backed by 1,229 individual customs records matching BIOCON PHARMA INC importing Calcium, covering 632 formulations from 3 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 184+ countries, 2,554+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Calcium Import Data for BIOCON PHARMA INC
Access order-level details, pricing data, supplier connections, and competitive analysis for BIOCON PHARMA INC's Calcium imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BIOCON PHARMA INC
Full Company Profile →
7 products · $110.0M total trade · 4 categories
BIOCON PHARMA INC × Calcium
Verified from customs records
Company Overview
Top Products by BIOCON PHARMA INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BIOCON PHARMA INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Calcium. For current order-level data, contact TransData Nexus.